An interventional study of Fast-forwarding in Cycle 1 and Goal-Setting plus Weekly Nudge in Cycle 1 in Diabetes, sponsored by National University of Singapore. Status unknown at 1 site in Singapore. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-09-28.
Sponsored by National University of Singapore · Not applicable, Interventional, and Other
Effective control of diabetes requires patients to change their daily behaviour. The investigators propose an intervention programme for behavioural change with two components, targeting motivation and implementation. The motivation component raises the salience of probable patient-specific detrimental future outcomes by 'fast-forwarding' awareness of these outcomes to the present. The implementation component helps patients to set goals and to act based on weekly tips. A factorial design will be used to establish the necessity and sufficiency of the two components on changing mind and guiding behaviour to improve blood glucose level. Individual-level measures of psychological, physical and medical conditions will be shown to drive the heterogenous responses to the two components. Intervention is expanded into two cycles with crossover design to demonstrate how the individual-level measures drive the wear-off, built-up and persistence of the two components. The results of this two-component programme will serve as a basis for systematic synthesis of component-level effectiveness in behavioural intervention research.
This behavioural-change-intervention programme will be an online 'single-centre' outpatient randomized controlled trial (RCT) with ten study arms. It will be a two-component intervention consisting of a motivation component of fast-forwarding and an implementation component of goal-setting and weekly nudges. The field intervention will be structured into a two-cycle four-treatment crossover design with four treatment conditions in the first cycle and crossing-over into eight treatment conditions (including one control condition) in the second cycle. In addition to the control group in the study, a group of patients from the Singapore Health Services (SingHealth) Diabetes Registry dataset will be identified using propensity scoring to serve as a 'match-pair' for each study participant. The electronic medical record of this match-pair will provide an additional benchmark of biological measure in addition to that provided by the control group.
The field study will run for 34 weeks, in two cycles of 14 weeks each, with a 2-week transition period between the two cycles. There will also be a 2-week baseline period in which baseline measurements will be taken before the first cycle begins and a 2-week debriefing period where the final measurement will be taken after the end of the second cycle. Measurements will be taken three times: once before Cycle 1 (as the baseline), once between Cycles 1 and 2, and once at the end of Cycle 2. Participants who are assigned to the motivation component of fast-forwarding will receive fast-forwarding immediately after the measurement session and before the cycle. The participants who are randomly assigned to treatment conditions, including the implementation component, will receive a weekly nudge programme with each 14-week cycle. All participants will have access to the resources used to generate the 14-week cycles.
The investigators will measure the following: (i) physiological and medical information related to the progression of diabetes; (ii) diet quality and exercise level; (iii) psychological reactions towards diabetes management; (iv) behavioural change readiness and commitment; and (v) lifestyle (smoking, alcohol consumption, and sleep quality).
11,090 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's enrollment of 225 is above the median of 80 across 8,491 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →National University of Singapore is the lead sponsor of 212 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Control condition
Weekly nudge intervention in Cycle 2
Behavioral: Goal-Setting plus Weekly Nudge in Cycle 2
Fast-forwarding interventions in both Cycles
Behavioral: Fast-forwarding in Cycle 1 · Behavioral: Fast-forwarding in Cycle 2
Fast-forwarding interventions in both Cycles, plus weekly nudge intervention in Cycle 2
Behavioral: Fast-forwarding in Cycle 1 · Behavioral: Fast-forwarding in Cycle 2 · Behavioral: Goal-Setting plus Weekly Nudge in Cycle 2
Weekly nudge intervention in Cycle 1
Behavioral: Goal-Setting plus Weekly Nudge in Cycle 1
Weekly nudge interventions in both Cycles
Behavioral: Goal-Setting plus Weekly Nudge in Cycle 1 · Behavioral: Goal-Setting plus Weekly Nudge in Cycle 2
Fast-forwarding interventions in both Cycles, plus weekly nudge intervention in Cycle 1
Behavioral: Fast-forwarding in Cycle 1 · Behavioral: Goal-Setting plus Weekly Nudge in Cycle 1 · Behavioral: Fast-forwarding in Cycle 2
All interventions applied in all Cycles
Behavioral: Fast-forwarding in Cycle 1 · Behavioral: Goal-Setting plus Weekly Nudge in Cycle 1 · Behavioral: Fast-forwarding in Cycle 2 · Behavioral: Goal-Setting plus Weekly Nudge in Cycle 2
Fast-forwarding intervention in Cycle 1
Behavioral: Fast-forwarding in Cycle 1
Fast-forwarding and weekly nudge interventions in Cycle 1
Behavioral: Fast-forwarding in Cycle 1 · Behavioral: Goal-Setting plus Weekly Nudge in Cycle 1
The fast-forwarding intervention will consist of a projection of future risk of co-morbidities. A visual projection model will be built using archival data available through the Singapore Diabetes Registry. The projection model will use the current profile of the participant to calculate a risk profile for the participant's potential complications and co-morbidities, which will be presented as a pie chart. The tool will also present alternative scenarios to the participant and visualize how the likelihood of complications or co-morbidities would decrease or increases if his/her habits changed. This will provide the motivational aspect of the intervention. This intervention takes place during Cycle 1 (first 14 weeks).
The procedure for goal-setting will start with the participant receiving a list of possible goals. The moderator will go through the list with the participant to identify which goals the participant is comfortable with and could reasonably achieve, and to tick off those goals that the participant has already achieved. The participants will choose their own goals. In each subsequent week, the moderator will check-in with the participant and tick off the goal(s) that have been achieved. Chat groups of 10-15 people will be formed to administer the weekly nudge. The participants will be encouraged to introduce themselves and to interact with each other during each the chat session. Every week for the following 14 weeks, the moderator will post diabetes-related content on the WhatsApp chat group and introduce topics of interest according to a planned schedule. This intervention takes place during Cycle 1 (first 14 weeks).
The fast-forwarding intervention will consist of a projection of future risk of co-morbidities. A visual projection model will be built using archival data available through the Singapore Diabetes Registry. The projection model will use the current profile of the participant to calculate a risk profile for the participant's potential complications and co-morbidities, which will be presented as a pie chart. The tool will also present alternative scenarios to the participant and visualize how the likelihood of complications or co-morbidities would decrease or increases if his/her habits changed. This will provide the motivational aspect of the intervention. This intervention takes place during Cycle 2 (second 14 weeks).
The procedure for goal-setting will start with the participant receiving a list of possible goals. The moderator will go through the list with the participant to identify which goals the participant is comfortable with and could reasonably achieve, and to tick off those goals that the participant has already achieved. The participants will choose their own goals. In each subsequent week, the moderator will check-in with the participant and tick off the goal(s) that have been achieved. Chat groups of 10-15 people will be formed to administer the weekly nudge. The participants will be encouraged to introduce themselves and to interact with each other during each the chat session. Every week for the following 14 weeks, the moderator will post diabetes-related content on the WhatsApp chat group and introduce topics of interest according to a planned schedule. This intervention takes place during Cycle 2 (second 14 weeks).
HbA1c after Cycle 1
Results from HbA1c test
Time frame: Measured between Weeks 17-18
HbA1c after Cycle 2
Results from HbA1c test
Time frame: Measured between Weeks 33-34
Diet quality after Cycle 1
Diet quality will be measured using the well-validated Food Frequency Questionnaire
Time frame: Measured between Weeks 17-18
Diet quality after Cycle 2
Diet quality will be measured using the well-validated Food Frequency Questionnaire
Time frame: Measured between Weeks 33-34
Exercise levels after Cycle 1
Exercise level will be assessed based on the Global Physical Activity Questionnaire (GPAQ) developed by the World Health Organization in 2002 for chronic disease risk-factor surveillance
Time frame: Measured between Weeks 17-18
Exercise levels after Cycle 2
Exercise level will be assessed based on the Global Physical Activity Questionnaire (GPAQ) developed by the World Health Organization in 2002 for chronic disease risk-factor surveillance
Time frame: Measured between Weeks 33-34
Attitudes towards diabetes management after Cycle 1
The participants' psychological reactions towards diabetes treatment will be captured using three main groups of questionnaires. Their general attitudes towards diabetes will be measured using the Diabetes Attitude Survey developed and validated by the University of Michigan Diabetes Research and Training Center (MDRC). The investigators will measure how strongly the patients feel empowered to cope with and manage diabetes, which is a crucial outcome of DSME. Empowerment will be captured using the Diabetes Empowerment Scale (DES) developed by the MDRC. To gain insight into the psychological processes through which fast-forwarding and implementation influence health outcomes, the investigators will measure attitudes towards perceived barriers to diet adherence, exercise, and monitoring, using the respective subscales of the Diabetes Care Profile developed by MDTC
Time frame: Measured between Weeks 17-18
Attitudes towards diabetes management after Cycle 2
The participants' psychological reactions towards diabetes treatment will be captured using three main groups of questionnaires. Their general attitudes towards diabetes will be measured using the Diabetes Attitude Survey developed and validated by the University of Michigan Diabetes Research and Training Center (MDRC). The investigators will measure how strongly the patients feel empowered to cope with and manage diabetes, which is a crucial outcome of DSME. Empowerment will be captured using the Diabetes Empowerment Scale (DES) developed by the MDRC. To gain insight into the psychological processes through which fast-forwarding and implementation influence health outcomes, the investigators will measure attitudes towards perceived barriers to diet adherence, exercise, and monitoring, using the respective subscales of the Diabetes Care Profile developed by MDTC
Time frame: Measured between Weeks 33-34
Readiness for behavioral change after Cycle 1
To assess readiness for behavioural change, the investigators will ask the participants to indicate their commitment to make changes to their diet and physical activity. Specifically, the investigators will ask them to name a food that they have been told to eat less of, and to indicate how many times they are willing to cut back on the food. Similarly, the investigators will ask the participants to indicate how much time per week they are willing to exercise to avoid future complications arising from their diabetes
Time frame: Measured between Weeks 17-18
Readiness for behavioral change after Cycle 2
To assess readiness for behavioural change, the investigators will ask the participants to indicate their commitment to make changes to their diet and physical activity. Specifically, the investigators will ask them to name a food that they have been told to eat less of, and to indicate how many times they are willing to cut back on the food. Similarly, the investigators will ask the participants to indicate how much time per week they are willing to exercise to avoid future complications arising from their diabetes
Time frame: Measured between Weeks 33-34
Smoking status after Cycle 1
Self-reported smoking status
Time frame: Measured between Weeks 17-18
Smoking status after Cycle 2
Self-reported smoking status
Time frame: Measured between Weeks 33-34
Level of alcohol consumption after Cycle 1
Self-reported frequency of alcohol consumption
Time frame: Measured between Weeks 17-18
Level of alcohol consumption after Cycle 2
Self-reported frequency of alcohol consumption
Time frame: Measured between Weeks 33-34
Sleep quality after Cycle 1
Self-reported quality of sleep
Time frame: Measured between Weeks 17-18
Sleep quality after Cycle 2
Self-reported quality of sleep
Time frame: Measured between Weeks 33-34
Plan to share: Yes — Investigators will not be storing or sharing any personal identifiers. All individual level data will be anonymized, and only anonymized data will be shared with other researchers, upon request.
Supporting information: Study protocol, Analytic code
Time frame: The supporting information will be made available upon publication in the supporting documentation.
Access criteria: It will be made available in the supporting documentation.
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National University of Singapore →